Insurers Pay Millions For Ivermectin For COVID-19, Even Though The Drug Doesn’t Work
MONDAY, Jan. 17, 2022– U.S. insurers are paying millions of dollars a year to cover the cost of ivermectin for COVID-19 patients despite a lack of proof the anti-parasitic drug is effective against the virus, a new study finds. Both the U.S. Food and Drug Administration and the World Health Organization say ivermectin pills— typically used to treat parasitic…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Outlook Consumer Electronics Extended Warranty Global Market to 2030 – Expansion of Products and Services Presents Opportunities
Crest Insurance Group Continues Rapid Expansion, Completing 13 Acquisitions in the Past Year: Crest Insurance Group
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News